|Market Price||$24.06||Daily Change||-$0.07||-0.29%|
HYLG seeks to generate income by writing covered calls on the Health Care Select Sector SPDR Fund.
By writing calls on 50% of the Health Care Select Sector SPDR Fund, the strategy allows investors to capture half the upside potential of the Health Care Select Sector Index.
HYLG seeks to make distributions on a monthly basis.
|Gross Expense Ratio||0.66%|
|Net Expense Ratio*||0.60%|
|Net Assets||$2.65 million|
|Fact Sheet||View the document|
*Fee waivers are contractual and in effect until at least March 1, 2024.
The Global X Health Care Covered Call & Growth ETF (HYLG) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Health Care Select Sector Index and the Health Care Select Sector SPDR Fund, and “writes” or “sells” corresponding call options on the Health Care Select Sector SPDR Fund representing approximately 50% of the value of HYLG’s portfolio.
The Global X Health Care Covered Call & Growth ETF (HYLG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P Health Care Select Sector Half BuyWrite Index.
|Bloomberg Index Ticker||BXLVH|
|Primary Exchange||NYSE Arca|
|Number of Holdings||68|
|30-Day Median Bid-Ask Spread||0.36%|
|30-Day SEC Yield||1.16%|
|Unsubsidized 30-Day SEC Yield||1.10%|
|Market Price||$24.06||Daily Change||-$0.07||-0.29%|
As of recent month & quarter-end (09/30/23)
|Fund NAV||Market Price||Index|
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
|Net Assets (%)||Ticker||Name||SEDOL||Market Price ($)||Shares Held||Market Value ($)|
|54.68||XLV||HEALTH CARE SELECT SECTOR||2371823||128.56||11,267||1,448,485.52|
|4.53||UNH||UNITEDHEALTH GROUP INC||2917766||514.57||233||119,894.81|
|4.08||LLY||ELI LILLY & CO||2516152||538.29||201||108,196.29|
|3.56||JNJ||JOHNSON & JOHNSON||2475833||155.15||607||94,176.05|
|2.47||MRK||MERCK & CO. INC.||2778844||102.55||637||65,324.35|
|1.15||BMY||BRISTOL-MYERS SQUIBB CO||2126335||57.85||526||30,429.10|
|0.98||ELV||ELEVANCE HEALTH INC||BSPHGL4||440.19||59||25,971.21|
|0.98||ISRG||INTUITIVE SURGICAL INC||2871301||294.98||88||25,958.24|
|0.88||GILD||GILEAD SCIENCES INC||2369174||74.10||315||23,341.50|
|0.84||CVS||CVS HEALTH CORP||2577609||69.69||318||22,161.42|
|0.81||CI||THE CIGNA GROUP||BHJ0775||287.54||75||21,565.50|
|0.73||BSX||BOSTON SCIENTIFIC CORP||2113434||52.81||365||19,275.65|
|0.71||BDX||BECTON DICKINSON AND CO||2087807||257.76||73||18,816.48|
|0.48||HCA||HCA HEALTHCARE INC||B4MGBG6||247.21||51||12,607.71|
|0.40||EW||EDWARDS LIFESCIENCES CORP||2567116||69.18||154||10,653.72|
|0.34||IQV||IQVIA HOLDINGS INC||BDR73G1||193.88||47||9,112.36|
|0.34||IDXX||IDEXX LABORATORIES INC||2459202||430.95||21||9,049.95|
|0.31||A||AGILENT TECHNOLOGIES INC||2520153||110.90||74||8,206.60|
|0.25||GEHC||GE HEALTHCARE TECHNOLOGY||BL6JPG8||67.84||97||6,580.48|
|0.22||ZBH||ZIMMER BIOMET HO||2783815||111.42||52||5,793.84|
|0.22||CAH||CARDINAL HEALTH INC||2175672||86.38||66||5,701.08|
|0.20||ALGN||ALIGN TECHNOLOGY INC||2679204||299.76||18||5,395.68|
|0.19||MOH||MOLINA HEALTHCARE INC||2212706||332.46||15||4,986.90|
|0.17||BAX||BAXTER INTERNATIONAL INC||2085102||37.35||122||4,556.70|
|0.14||COO||COOPER COS INC/THE||2222631||311.90||12||3,742.80|
|0.13||DGX||QUEST DIAGNOSTICS INC||2702791||120.91||29||3,506.39|
|0.10||CRL||CHARLES RIVER LA||2604336||193.39||13||2,514.07|
|0.09||HSIC||HENRY SCHEIN INC||2416962||73.30||33||2,418.90|
|0.07||XRAY||DENTSPLY SIRONA INC||BYNPPC6||33.78||55||1,857.90|
|0.04||OGN||ORGANON & CO||BLDC8J4||16.69||66||1,101.54|
|-0.02||OTHER PAYABLE & RECEIVABLES||1.00||-408||-407.82|
|-0.15||2XLV US 10/20/2023 C133||39.50||-102||-4,029.39|
Investing involves risk, including the possible loss of principal. Concentration in a particular industry or sector will subject HYLG to loss due to adverse occurrences that may affect that industry or sector. Investors in HYLG should be willing to accept a high degree of volatility in the price of the fund’s shares and the possibility of significant losses. The health care industry could be adversely affected by various political, regulatory, supply-and-demand, and other economic factors.
HYLG engages in options trading. An option is a contract sold by one party to another that gives the buyer the right, but not the obligation, to buy (call) or sell (put) a stock at an agreed upon price within a certain period or on a specific date. A covered call option involves holding a long position in a particular asset, in this case U.S. common equities, and writing a call option on that same asset with the goal of realizing additional income from the option premium. By selling covered call options, the fund limits its opportunity to profit from an increase in the price of the underlying index above the exercise price, but continues to bear the risk of a decline in the index. A liquid market may not exist for options held by the fund. While the fund receives premiums for writing the call options, the price it realizes from the exercise of an option could be substantially below the indices current market price. HYLG is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. The market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share, and do not represent the returns you would receive if you traded shares at other times. NAVs are calculated using prices as of 4:00 PM Eastern Time. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Cboe, nor does Cboe make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Cboe.